HPS are pleased to announce the award of a further clinical trial contract to manufacture investigative medicinal products. Under the terms of the agreement between HPS and a major UK Medical School, HPS will be responsible for the cGMP formulation and manufacture of a nasally administered dosage form to be administered to human participants as […]
HPS is delighted to announce that it has been successful in securing a 5 year framework agreement with a leading UK University to provide Clinical Trial services covering amongst other areas, the manufacture, labelling, packaging, import and distribution of investigative medicinal products (IMPs) and placebos.
HPS is pleased to announce that it has been selected to deliver logistics and supply services in the UK on behalf of an internationally sponsored clinical trial investigating advanced breast cancer.
Sterile team member Amy Woodward has been knitting some special blankets for some extra special babies. Knitting since she was 19, Amy, has spent time making baby related items for her friends and family. Now, Amy has turned to creating pieces for the Special Care Baby Unit at Calderdale Hospital. When asked what had inspired […]
Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to formulate and manufacture active and placebo medicines for a Phase II blinded, randomised, three arm placebo controlled and adaptive designed clinical trial in-order to advance treatment options for patients diagnosed with Motor Neurone Disease. HPS will be responsible for […]
One of the trainee Clinical Scientists working for Huddersfield Pharmacy Specials is spending a month in a hospital based in Nepal as part of the Scientist Training Programme. What is the Scientist Training Programme? The Scientist Training Programme is a national three year postgraduate training programme developed to train the next generation of healthcare scientists. […]
Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to formulate and manufacture active and placebo medicines for a pragmatic, multicentre, randomised controlled trial of active versus placebo in patients clinically at high-risk of developing psychosis. HPS will be responsible for and advising upon the investigational medicinal product dossier (IMPD), […]
Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to design packaging and supply medicines for a large scale two arm, multicentre, randomised controlled trial to investigate treatments to reduce seizure frequency in patients diagnosed with glioma.
Huddersfield Pharmacy Specials (HPS) is delighted to announce that is been contracted by a global big pharma organisation to research and develop products in a pre-filled syringe dosage form with a view for such products to be submitted for marketing authorisation and for eventual global sale.
Huddersfield Pharmacy Specials (HPS) is delighted to announce that it has won a multi-year contract research project to research, develop and manufacture a novel fluid designed to improve the viability of donor human organs, such as liver and kidney, that have been removed for pending transplant into recipients. As well as research and development, HPS […]
